Placebo to match ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680
ALKS 2680-201
Phase 2 small_molecule active
Quick answer
Placebo to match ALKS 2680, ALKS 2680, ALKS 2680, ALKS 2680 for Narcolepsy Type 1 is a Phase 2 program (small_molecule) at Alkermes Pharma Ireland with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alkermes Pharma Ireland
- Indication
- Narcolepsy Type 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active